<code id='11E9CE3756'></code><style id='11E9CE3756'></style>

<acronym id='11E9CE3756'></acronym>

<center id='11E9CE3756'><center id='11E9CE3756'><tfoot id='11E9CE3756'></tfoot></center><abbr id='11E9CE3756'><dir id='11E9CE3756'><tfoot id='11E9CE3756'></tfoot><noframes id='11E9CE3756'>

<optgroup id='11E9CE3756'><strike id='11E9CE3756'><sup id='11E9CE3756'></sup></strike><code id='11E9CE3756'></code></optgroup>

<b id='11E9CE3756'><label id='11E9CE3756'><select id='11E9CE3756'><dt id='11E9CE3756'><span id='11E9CE3756'></span></dt></select></label></b><u id='11E9CE3756'></u>

~~<i id='11E9CE3756'><strike id='11E9CE3756'><tt id='11E9CE3756'><pre id='11E9CE3756'></pre></tt></strike></i>~~

Home» focus» fashion

fashion

fashion

author：explore 2025-09-30 14:55:13 Page View：7

Adobe

For a decade, leading academic institutes and their associated companies fought a bruising, headline-grabbing fight over who held patent rights to CRISPR-Cas9, the revolutionary genome editing tool.

Editas Medicine, the winner of that battle in the U.S., will now cash in.

advertisement

Vertex Pharmaceuticals and Editas announced Wednesday that Vertex will pay Editas $50 million, along with a series of annual payments through 2034, in exchange for rights to use CRISPR-Cas9 in Casgevy, the sickle cell therapy approved last week.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Donor acceptance rates hint at racial, gender bias in heart transplants: study
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

George Santos makes 1st court appearance after pleading not guilty to 13 counts

1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

Merck drug for rare lung condition set for approval in U.S.

Merck drug for rare lung condition set for approval in U.S.

AdobeTheFoodandDrugAdministrationisexpectedtoapproveMerck’sdrugtotreatararelungdisordercalledpulmona

Hollywood unions extend contract negotiations for actors

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

'Investigate these claims': UFO transparency at center of House hearing

3:47RyanGraves,DavidGrusch,andDavidFravorattendtheHouseOversight&AccountabilityCommittee'sNationalSe

read more